Read the March 2015 Issue
In this issue, authors discuss two growing trends in drug use and its management, and you can read about a new CAP proficiency testing program.
CFTN is registered with the U.S. Library of Congress and has been assigned ISSN 2374-9679. We look forward to your feedback or comments.
Nicotine Delivery Systems Offer New Option, But Are They Safer?
By Jennifer Colby, PhD
Use of electronic nicotine delivery systems (ENDS) has exploded in popularity. Most of these devices are airflow-activated, battery-powered atomizers that heat a nicotine solution to produce a vapor that is inhaled. In addition to nicotine, other tobacco alkaloids, including cotinine and anabsine, have been detected in vapor from some brands. Inhaling the vaporized solution can have an impact on clinical lab test results.
Preventing Opioid Abuse
Prescription Drug Monitoring Programs Can Play Important Role
By Jacob T. Painter, PharmD, MBA, PhD and Daniel Cobaugh, PharmD, DABAT, FAACT
In an effort to reduce the morbidity and mortality associated with opioid abuse in the U.S., most states have implemented prescription drug monitoring programs (PDMPs). As they continue to evolve, these programs are expected to play a critical role in managing patients on chronic opioid therapy. Surveys indicate that providers with access to PDMPs are likely to reevaluate their prescribing practices based on PDMP information.
New Drug-Facilitated Crime PT Program Starts in June
This new survey offers a qualitative urine drug analysis with confirmation testing. The current list of drugs in each PT challenge will be listed on CAP’s website under the Laboratory Improvements tab.